Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- Check7 days agoChange DetectedFooter revision indicator updated from v3.4.1 to v3.4.2; no other content or study details appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision indicator updated in the page footer from v3.4.0 to v3.4.1. There are no observed changes to the study's content or site navigation.SummaryDifference0.1%

- Check22 days agoChange DetectedShow glossary toggle has been added to the page. QC-related and version metadata have been updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', replacing the prior labels and text such as 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4', with capitalization adjustments for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. This appears to be a minor metadata/version update.SummaryDifference0.1%

- Check58 days agoChange DetectedLocations section now lists Massachusetts as a study site. The older Massachusetts Locations entry and the HHS Vulnerability Disclosure were removed, and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check86 days agoChange DetectedPublication notes were updated to clarify that publications are provided voluntarily by the person entering information and pertain to the study results. The revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.